|
Search
Collections
Benchmarks
Upload document
Organization
CPDM
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
B-LYMPHOCYTE CHEMOATTRACTANT (BLC/CXCL13): A POTENTIAL NOVEL DISEASE ACTIVITY MARKER OF RHEUMATOID ARTHRITIS
Org:
RA DSCB,
CPDM,
BDS,
GlaxoSmithKline,
Stevenage,
